Crowdfunding

We have a gift for your kindness!

Claim Gift
LIVE


Support Khushi Yadav

ImpactGuru has waived off its fee for this cause
Campaign verification in progress Impactguru

"A Daily Battle, A Shared Hope: Stand With Khushi Against SMA

"A Daily Battle, A Shared Hope: Stand With Khushi Against SMA

P
Campaigner Details
Impactguru Verified

Palash
Mumbai Maharashtra Contact
KY
Beneficiary Details
Impactguru Impactguru

Khushi Yadav
Helping Khushi Yadav
Patient is currently not admitted

of $ 11,765

1 Donors
Funds will be transferred for patient's treatment
Impactguru
Every social media share can bring $80
P
Campaigner Details
Impactguru Verified

Palash
Mumbai Maharashtra | Contact
KY
Beneficiary Details
Impactguru Impactguru

Khushi Yadav
Helping Khushi Yadav
Patient is currently not admitted

Story


“Support Baby Khushi Yadav’s Fight Against SMA — Every Day Counts, Every Bit of Help Brings Hope. Kindly contribute and share to Bring Her Zolgensma Treatment Closer.”

Her Story: A Fight Against SMA



My name is Aarti Kumari Yadav. I am a mother, and I am watching my only child, 20-month-old daughter, Khushi, fight the bravest battle of her life against Spinal Muscular Atrophy (SMA) Type 2, which is slowly eating her life. She can not stand or walk, has lost reflexes in her ankle and knee, is losing strength to keep her back straight, and frequently gets long bouts of cold requiring a nebuliser. A progressive disease, leading to an eventual loss of life, which every parent dreads to even dream of.


Her name means "Happiness," and she has filled our lives with more joy than we ever thought possible when she came to this world on 09/02/2024. Her smile can light up the darkest room, and her spirit is so bright and aware. But every day, this cruel disease tries to dim that light. We have a chance to stop it, but we cannot do it alone. We need your help to secure her only hope: a one-time gene therapy called Zolgensma from Novartis, costing Rs 16 cr.


A Mother's Plea: What is SMA?


As a mother, my instinct is to protect my child. But how do you protect her from something inside her own body?


Khushi, my little girl, has been diagnosed with SMA Type 2. It is a rare genetic disorder affecting 1 in 10,000 children. It is caused by the mutation or deletion of the SMN1 gene, which is responsible for producing a vital protein needed for motor neurons. Without it, these neurons fail to function, leading to:

· Progressive muscle weakness

· Loss of movement

· Swallowing and feeding difficulties

· spine curves sideways

· Breathing problems, leading to respiratory failure


“SMA is a thief in the night, silently stealing the strength from my daughter’s limbs, but it can never touch the fierce light in her eyes.”


When I look into Khushi's eyes, I see a vibrant little girl who wants to explore the world. I see the determination, I hear her laughter, and I feel her love. I also see the frustration when her body won't do what her mind wants it to. This is the heartbreaking reality of SMA.


The Light at the End of the Tunnel: Zolgensma


In our deepest despair, we found a beacon of hope: Zolgensma.


This isn't just a medicine; it's a one-time miracle treatment. It is a one-time intravenous (IV) infusion and works by delivering a functional copy of the SMN1 gene to help restore motor function and prevent disease progression. Zolgensma can allow children to gain mobility and strength, giving them a chance to live.


The challenge is its astronomical Cost of treating this: ₹16 crore, which, after tax waivers and the instalment scheme from Novartis, comes to an estimated cost of treatment of ₹9.5 crore.


“Hope is the little voice you hear whisper ‘maybe’ when the entire world is shouting ‘no’.”


Zolgensma is our "maybe." It is the promise of a future where Khushi is not defined by her disease, but by her dreams.


The Uphill Task

The clock is ticking for us; the Zolgesma gene therapy has to be administered as early as possible before the age of 2 years. We have four months before Khushi turns 2 years on 09/02/2026. We are racing against time. Not only is her body losing strength and degenerating, but her treatment window is also narrowing. In the meantime, on the advice of doctors, she has been started on risdipalm, an oral medicine to slow down her motor neuron degeneration temporarily. This oral syrup, one bottle itself costs Rs.. 6.5 lakh lasting only 30 days.


We Cannot Do This Alone

As parents, we would give anything for our child. The cost of this treatment is astronomical, a sum that feels insurmountable. But we believe in the power of community. We believe that when many people come together, miracles can happen.


· Your support is not just a donation; it is a lifeline.

· Sharing our story helps us reach compassionate hearts we could never find on our own.

· Every contribution, no matter the size, is a step closer to saving our daughter’s life.


“Sometimes, miracles are just good people with kind hearts.”


We are asking you to be that miracle for Khushi. We are asking you to be her angel who helps a baby get her future back.


Join Us in Khushi's Fight


Please, help us to save our daughter's life and give her the childhood she deserves. Help us turn her story from one of struggle into one of triumph. All our hope lies in your support and contribution today. Pls donate for her treatment and share her story.


You can reach out to us on:-

Contact: [email protected]

Follow Our Journey: https://linktr.ee/khushi_fights_SMA


बच्ची खुशि को स्पाइनल मस्कुलर एट्रोफी (SMA) टाइप 2, एक आनुवंशिक बीमारी है।

Zolgensma नामक जीवन रक्षक जीन थेरेपी उसके जीवन को बचा सकता है।

इस इलाज की लागत ₹9.5 करोड़ है।

कृपया मदद करें और इसे साझा करें, ताकि अन्य लोग भी इस बच्ची के जीवन रक्षण कार्य के लिए प्रेरित हो सकें।


With all the hope in my heart,

Aarti Yadav (Khushi’s Mother)

The goal amount of the campaign may be higher than the attached estimates to address and aid the post-hospitalization expenses/contingencies including but not limited to prolonged medication, diagnostics, rehabilitation therapies, and follow-up doctor visits/consultations which vary from disease to disease.
NO INFLUENCE DECLARATION
Impact Guru does not influence / control the decision of the campaigner / patient with respect to choice of hospital / doctor / healthcare treatment or the cost / estimate of any such treatment. Such decision is in entirety of campaigner / patient / beneficiary and / or their family members without any interference and / or say of Impact Guru. Impact Guru is absolved of any liability in respect thereof.
LANGUAGE OF STORY/STATEMENT DECLARATION
The language, story, facts mentioned on this fundraising page is in entirety statements / opinions / thoughts shared by the campaigner / beneficiary or persons authorised on their behalf and shall not be construed as statement / thoughts / opinions of or on behalf of Impact Guru.
TREATMENT COST ESTIMATES
Impact Guru has no control over the cost estimates provided by hospitals / clinics / pharmaceutical companies etc. The cost estimates vary depending on the city and / or hospital where the patient is under treatment, professional fees of the treating doctors, drugs / medicines / therapies chosen for treatment by patient or patient’s family at their own discretion including but not limited to unique medical conditions / circumstances pertaining to each patient.
UTILIZATION OF FUNDS
In the rare scenario of surplus funds remaining within the fundraising campaign due to any of the following circumstances:
i) Completion of the Patient's treatment; ii) Receipt of requisite funding for the Patient from alternative sources; iii) Eligibility of the Patient for free treatment under any scheme or the receipt of free treatment by other means; iv) Demise of the Patient; v) Fulfilment of the fundraising campaign's objectives; vi) Termination of the fundraising campaign for any reason; vii) Reduction in the cost of the drug/therapy required for SMA treatment; viii) Prescription of an alternative therapy for the Patient's treatment
Impact Guru shall ensure that such surplus funds are allocated for the following purposes:
i) Provision of alternative drug therapy treatments as prescribed by the attending physician for the Patient/s (if applicable). Such utilization may span across multiple years, as SMA therapies/treatments typically entail long-term, recurring costs; ii) If surplus funds persist even after the aforementioned allocation, they shall be employed to assist other patients on Impact Guru in their life-saving treatment, with the objective of maximizing social impact; iii) donors of the fundraising campaign at the sole discretion of Impact Guru may be offered the option to claim a pro-rata refund of surplus funds.

Comment


Top Influencers


Impactguru


Fundraisers for This Cause




Touch more lives with your Kindness !

playstore
X

Access and manage fundraisers at your fingertips!

Get important fundraising tips, a personalized dashboard and real-time updates with ImpactGuru’s new and improved crowdfunding app.

qrcode

Scan the QR code to download the app

mobile-out-image
mobile-inside-image